» Articles » PMID: 35103856

RNF144A Exerts Tumor Suppressor Function in Breast Cancer Through Targeting YY1 for Proteasomal Degradation to Downregulate GMFG Expression

Overview
Journal Med Oncol
Publisher Springer
Specialty Oncology
Date 2022 Feb 1
PMID 35103856
Authors
Affiliations
Soon will be listed here.
Abstract

Ring finger protein 144A (RNF144A), a poorly characterized member of the RING-in-between-RING family of E3 ubiquitin ligases, is an emerging tumor suppressor, but its underlying mechanism remains largely elusive. To address this issue, we used Affymetrix GeneChip Human Transcriptome Array 2.0 to profile gene expression in MDA-MB-231 cells stably expressing empty vector pCDH and Flag-RNF144A, and found that 128 genes were differentially expressed between pCDH- and RNF144A-expressing cells with fold change over 1.5. We further demonstrated that RNF144A negatively regulated the protein and mRNA levels of glial maturation factor γ (GMFG). Mechanistical investigations revealed that transcription factor YY1 transcriptionally activated GMFG expression, and RNF144A interacted with YY1 and promoted its ubiquitination-dependent degradation, thus blocking YY1-induced GMFG expression. Functional rescue assays showed that ectopic expression of RNF144A suppressed the proliferative, migratory, and invasive potential of breast cancer cells, and the noted effects were partially restored by re-expression of GMFG in RNF144A-overexpressing breast cancer cells. Collectively, these findings reveal that RNF144A negatively regulates GMFG expression by targeting YY1 for proteasomal degradation, thus inhibiting the proliferation, migration, and invasion of breast cancer cells.

Citing Articles

Sirt6 Mono-ADP-Ribosylates YY1 to Promote Dystrophin Expression for Neuromuscular Transmission.

Zhang W, Bai L, Xu W, Liu J, Chen Y, Lin W Adv Sci (Weinh). 2024; 11(44):e2406390.

PMID: 39387251 PMC: 11600243. DOI: 10.1002/advs.202406390.


Genome-Wide Association Study of Body Conformation Traits in Tashi Goats ().

Yang R, Zhou D, Tan X, Zhao Z, Lv Y, Tian X Animals (Basel). 2024; 14(8).

PMID: 38672293 PMC: 11047570. DOI: 10.3390/ani14081145.


A ubiquitination-related risk model for predicting the prognosis and immunotherapy response of gastric adenocarcinoma patients.

Shao S, Sun Y, Zhao D, Tian Y, Yang Y, Luo N PeerJ. 2024; 12:e16868.

PMID: 38313020 PMC: 10838090. DOI: 10.7717/peerj.16868.


Comprehensive analysis of senescence-associated genes in sepsis based on bulk and single-cell sequencing data.

Tao L, Zhu Y, Wu L, Liu J Front Mol Biosci. 2024; 10:1322221.

PMID: 38259686 PMC: 10801732. DOI: 10.3389/fmolb.2023.1322221.


Zinc Ions Modulate YY1 Activity: Relevance in Carcinogenesis.

Figiel M, Gorka A, Gorecki A Cancers (Basel). 2023; 15(17).

PMID: 37686614 PMC: 10487186. DOI: 10.3390/cancers15174338.


References
1.
Yang W, Feng B, Meng Y, Wang J, Geng B, Cui Q . FAM3C-YY1 axis is essential for TGFβ-promoted proliferation and migration of human breast cancer MDA-MB-231 cells via the activation of HSF1. J Cell Mol Med. 2019; 23(5):3464-3475. PMC: 6484506. DOI: 10.1111/jcmm.14243. View

2.
Gao Q, Wang S, Zhang Z . E3 ubiquitin ligase SMURF2 prevents colorectal cancer by reducing the stability of the YY1 protein and inhibiting the SENP1/c-myc axis. Gene Ther. 2021; 30(1-2):51-63. DOI: 10.1038/s41434-021-00289-z. View

3.
Bloom J, Amador V, Bartolini F, DeMartino G, Pagano M . Proteasome-mediated degradation of p21 via N-terminal ubiquitinylation. Cell. 2003; 115(1):71-82. DOI: 10.1016/s0092-8674(03)00755-4. View

4.
Aerbajinai W, Liu L, Chin K, Zhu J, Parent C, Rodgers G . Glia maturation factor-γ mediates neutrophil chemotaxis. J Leukoc Biol. 2011; 90(3):529-38. PMC: 3157903. DOI: 10.1189/jlb.0710424. View

5.
Jeong H, Lee S, Yum J, Yeo C, Lee K . Smurf2 regulates the degradation of YY1. Biochim Biophys Acta. 2014; 1843(9):2005-11. DOI: 10.1016/j.bbamcr.2014.04.023. View